Efficacy and Safety of KI1001 in ≥ 55 Years Old Insomnia Patients
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
KI1001(Circadin®, Prolonged release tablet which contains melatonin) has showed its efficacy
to improve sleep quality in over 55 years old primary insomnia patients. This is a bridging
study to investigate the efficacy and safety of KI1001(Circadin®) in Korean patients.